Feasibility of Reduced-Intensity Cord Blood Transplantation as Salvage Therapy for Graft Failure: Results of a Nationwide Survey of Adult Patients

Fusako Waki, Kazuhiro Masuoka, Takahiro Fukuda, Yoshinobu Kanda, Mika Nakamae, Kimikazu Yakushijin, Katsuhiro Togami, Kaichi Nishiwaki, Yasunori Ueda, Fumio Kawano, Masaharu Kasai, Koji Nagafuji, Maki Hagihara, Kazuo Hatanaka, Masafumi Taniwaki, Yoshinobu Maeda, Naoki Shirafuji, Takehiko Mori, Atae Utsunomiya, Tetsuya EtoHitoshi Nakagawa, Makoto Murata, Toshiki Uchida, Hiroatsu Iida, Kazuaki Yakushiji, Takuya Yamashita, Atsushi Wake, Satoshi Takahashi, Yoichi Takaue, Shuichi Taniguchi

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

To evaluate whether rescue with cord blood transplantation (CBT) could improve the poor survival after graft failure (GF), we surveyed the data of 80 adult patients (median age, 51 years) who received CBT within 3 months of GF (primary 64, secondary 16), with fludarabine-based reduced-intensity regimens with or without melphalan, busulfan, cyclophosphamide, and/or 2-4 Gy total-body irradiation (TBI). A median number of 2.4 × 107/kg total nucleated cells (TNC) were infused, and among the 61 evaluable patients who survived for more than 28 days, 45 (74%) engrafted. The median follow-up of surviving patients was 325 days, and the 1-year overall survival rate was 33% despite poor performance status (2-4, 60%), carryover organ toxicities (grade 3/4, 14%), and infections (82%) prior to CBT. Day 100 transplantation-related mortality was 45%, with 60% related to infectious complications. Multivariate analysis showed that the infusion of TNC ≥2.5 × 107/kg and an alkylating agent-containing regimen were associated with a higher probability of engraftment, and that high risk-status at the preceding transplantation and grade 3/4 organ toxicities before CBT were associated with an increased risk of mortality. In conclusion, in an older population of patients, our data support the feasibility of CBT with a reduced-intensity conditioning regimen for GF.

Original languageEnglish
Pages (from-to)841-851
Number of pages11
JournalBiology of Blood and Marrow Transplantation
Volume17
Issue number6
DOIs
Publication statusPublished - 2011 Jun

Fingerprint

Salvage Therapy
Fetal Blood
Transplantation
Transplants
Busulfan
Melphalan
Mortality
Whole-Body Irradiation
Alkylating Agents
Graft Survival
Surveys and Questionnaires
Cyclophosphamide
Multivariate Analysis
Survival Rate
Infection
Population

Keywords

  • Allogeneic stem cell transplantation
  • Cord blood transplantation
  • Graft failure
  • Reduced intensity
  • Rejection

ASJC Scopus subject areas

  • Transplantation
  • Hematology

Cite this

Feasibility of Reduced-Intensity Cord Blood Transplantation as Salvage Therapy for Graft Failure : Results of a Nationwide Survey of Adult Patients. / Waki, Fusako; Masuoka, Kazuhiro; Fukuda, Takahiro; Kanda, Yoshinobu; Nakamae, Mika; Yakushijin, Kimikazu; Togami, Katsuhiro; Nishiwaki, Kaichi; Ueda, Yasunori; Kawano, Fumio; Kasai, Masaharu; Nagafuji, Koji; Hagihara, Maki; Hatanaka, Kazuo; Taniwaki, Masafumi; Maeda, Yoshinobu; Shirafuji, Naoki; Mori, Takehiko; Utsunomiya, Atae; Eto, Tetsuya; Nakagawa, Hitoshi; Murata, Makoto; Uchida, Toshiki; Iida, Hiroatsu; Yakushiji, Kazuaki; Yamashita, Takuya; Wake, Atsushi; Takahashi, Satoshi; Takaue, Yoichi; Taniguchi, Shuichi.

In: Biology of Blood and Marrow Transplantation, Vol. 17, No. 6, 06.2011, p. 841-851.

Research output: Contribution to journalArticle

Waki, F, Masuoka, K, Fukuda, T, Kanda, Y, Nakamae, M, Yakushijin, K, Togami, K, Nishiwaki, K, Ueda, Y, Kawano, F, Kasai, M, Nagafuji, K, Hagihara, M, Hatanaka, K, Taniwaki, M, Maeda, Y, Shirafuji, N, Mori, T, Utsunomiya, A, Eto, T, Nakagawa, H, Murata, M, Uchida, T, Iida, H, Yakushiji, K, Yamashita, T, Wake, A, Takahashi, S, Takaue, Y & Taniguchi, S 2011, 'Feasibility of Reduced-Intensity Cord Blood Transplantation as Salvage Therapy for Graft Failure: Results of a Nationwide Survey of Adult Patients', Biology of Blood and Marrow Transplantation, vol. 17, no. 6, pp. 841-851. https://doi.org/10.1016/j.bbmt.2010.09.005
Waki, Fusako ; Masuoka, Kazuhiro ; Fukuda, Takahiro ; Kanda, Yoshinobu ; Nakamae, Mika ; Yakushijin, Kimikazu ; Togami, Katsuhiro ; Nishiwaki, Kaichi ; Ueda, Yasunori ; Kawano, Fumio ; Kasai, Masaharu ; Nagafuji, Koji ; Hagihara, Maki ; Hatanaka, Kazuo ; Taniwaki, Masafumi ; Maeda, Yoshinobu ; Shirafuji, Naoki ; Mori, Takehiko ; Utsunomiya, Atae ; Eto, Tetsuya ; Nakagawa, Hitoshi ; Murata, Makoto ; Uchida, Toshiki ; Iida, Hiroatsu ; Yakushiji, Kazuaki ; Yamashita, Takuya ; Wake, Atsushi ; Takahashi, Satoshi ; Takaue, Yoichi ; Taniguchi, Shuichi. / Feasibility of Reduced-Intensity Cord Blood Transplantation as Salvage Therapy for Graft Failure : Results of a Nationwide Survey of Adult Patients. In: Biology of Blood and Marrow Transplantation. 2011 ; Vol. 17, No. 6. pp. 841-851.
@article{9769b098f505498b8add7096cc153355,
title = "Feasibility of Reduced-Intensity Cord Blood Transplantation as Salvage Therapy for Graft Failure: Results of a Nationwide Survey of Adult Patients",
abstract = "To evaluate whether rescue with cord blood transplantation (CBT) could improve the poor survival after graft failure (GF), we surveyed the data of 80 adult patients (median age, 51 years) who received CBT within 3 months of GF (primary 64, secondary 16), with fludarabine-based reduced-intensity regimens with or without melphalan, busulfan, cyclophosphamide, and/or 2-4 Gy total-body irradiation (TBI). A median number of 2.4 × 107/kg total nucleated cells (TNC) were infused, and among the 61 evaluable patients who survived for more than 28 days, 45 (74{\%}) engrafted. The median follow-up of surviving patients was 325 days, and the 1-year overall survival rate was 33{\%} despite poor performance status (2-4, 60{\%}), carryover organ toxicities (grade 3/4, 14{\%}), and infections (82{\%}) prior to CBT. Day 100 transplantation-related mortality was 45{\%}, with 60{\%} related to infectious complications. Multivariate analysis showed that the infusion of TNC ≥2.5 × 107/kg and an alkylating agent-containing regimen were associated with a higher probability of engraftment, and that high risk-status at the preceding transplantation and grade 3/4 organ toxicities before CBT were associated with an increased risk of mortality. In conclusion, in an older population of patients, our data support the feasibility of CBT with a reduced-intensity conditioning regimen for GF.",
keywords = "Allogeneic stem cell transplantation, Cord blood transplantation, Graft failure, Reduced intensity, Rejection",
author = "Fusako Waki and Kazuhiro Masuoka and Takahiro Fukuda and Yoshinobu Kanda and Mika Nakamae and Kimikazu Yakushijin and Katsuhiro Togami and Kaichi Nishiwaki and Yasunori Ueda and Fumio Kawano and Masaharu Kasai and Koji Nagafuji and Maki Hagihara and Kazuo Hatanaka and Masafumi Taniwaki and Yoshinobu Maeda and Naoki Shirafuji and Takehiko Mori and Atae Utsunomiya and Tetsuya Eto and Hitoshi Nakagawa and Makoto Murata and Toshiki Uchida and Hiroatsu Iida and Kazuaki Yakushiji and Takuya Yamashita and Atsushi Wake and Satoshi Takahashi and Yoichi Takaue and Shuichi Taniguchi",
year = "2011",
month = "6",
doi = "10.1016/j.bbmt.2010.09.005",
language = "English",
volume = "17",
pages = "841--851",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Feasibility of Reduced-Intensity Cord Blood Transplantation as Salvage Therapy for Graft Failure

T2 - Results of a Nationwide Survey of Adult Patients

AU - Waki, Fusako

AU - Masuoka, Kazuhiro

AU - Fukuda, Takahiro

AU - Kanda, Yoshinobu

AU - Nakamae, Mika

AU - Yakushijin, Kimikazu

AU - Togami, Katsuhiro

AU - Nishiwaki, Kaichi

AU - Ueda, Yasunori

AU - Kawano, Fumio

AU - Kasai, Masaharu

AU - Nagafuji, Koji

AU - Hagihara, Maki

AU - Hatanaka, Kazuo

AU - Taniwaki, Masafumi

AU - Maeda, Yoshinobu

AU - Shirafuji, Naoki

AU - Mori, Takehiko

AU - Utsunomiya, Atae

AU - Eto, Tetsuya

AU - Nakagawa, Hitoshi

AU - Murata, Makoto

AU - Uchida, Toshiki

AU - Iida, Hiroatsu

AU - Yakushiji, Kazuaki

AU - Yamashita, Takuya

AU - Wake, Atsushi

AU - Takahashi, Satoshi

AU - Takaue, Yoichi

AU - Taniguchi, Shuichi

PY - 2011/6

Y1 - 2011/6

N2 - To evaluate whether rescue with cord blood transplantation (CBT) could improve the poor survival after graft failure (GF), we surveyed the data of 80 adult patients (median age, 51 years) who received CBT within 3 months of GF (primary 64, secondary 16), with fludarabine-based reduced-intensity regimens with or without melphalan, busulfan, cyclophosphamide, and/or 2-4 Gy total-body irradiation (TBI). A median number of 2.4 × 107/kg total nucleated cells (TNC) were infused, and among the 61 evaluable patients who survived for more than 28 days, 45 (74%) engrafted. The median follow-up of surviving patients was 325 days, and the 1-year overall survival rate was 33% despite poor performance status (2-4, 60%), carryover organ toxicities (grade 3/4, 14%), and infections (82%) prior to CBT. Day 100 transplantation-related mortality was 45%, with 60% related to infectious complications. Multivariate analysis showed that the infusion of TNC ≥2.5 × 107/kg and an alkylating agent-containing regimen were associated with a higher probability of engraftment, and that high risk-status at the preceding transplantation and grade 3/4 organ toxicities before CBT were associated with an increased risk of mortality. In conclusion, in an older population of patients, our data support the feasibility of CBT with a reduced-intensity conditioning regimen for GF.

AB - To evaluate whether rescue with cord blood transplantation (CBT) could improve the poor survival after graft failure (GF), we surveyed the data of 80 adult patients (median age, 51 years) who received CBT within 3 months of GF (primary 64, secondary 16), with fludarabine-based reduced-intensity regimens with or without melphalan, busulfan, cyclophosphamide, and/or 2-4 Gy total-body irradiation (TBI). A median number of 2.4 × 107/kg total nucleated cells (TNC) were infused, and among the 61 evaluable patients who survived for more than 28 days, 45 (74%) engrafted. The median follow-up of surviving patients was 325 days, and the 1-year overall survival rate was 33% despite poor performance status (2-4, 60%), carryover organ toxicities (grade 3/4, 14%), and infections (82%) prior to CBT. Day 100 transplantation-related mortality was 45%, with 60% related to infectious complications. Multivariate analysis showed that the infusion of TNC ≥2.5 × 107/kg and an alkylating agent-containing regimen were associated with a higher probability of engraftment, and that high risk-status at the preceding transplantation and grade 3/4 organ toxicities before CBT were associated with an increased risk of mortality. In conclusion, in an older population of patients, our data support the feasibility of CBT with a reduced-intensity conditioning regimen for GF.

KW - Allogeneic stem cell transplantation

KW - Cord blood transplantation

KW - Graft failure

KW - Reduced intensity

KW - Rejection

UR - http://www.scopus.com/inward/record.url?scp=79956004870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956004870&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2010.09.005

DO - 10.1016/j.bbmt.2010.09.005

M3 - Article

C2 - 20849969

AN - SCOPUS:79956004870

VL - 17

SP - 841

EP - 851

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 6

ER -